Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 31 | 2023 | 116 | 8.360 |
Why?
|
| Pulmonary Emphysema | 12 | 2021 | 23 | 3.700 |
Why?
|
| Osteoporosis | 8 | 2022 | 51 | 2.340 |
Why?
|
| Smoking | 15 | 2023 | 505 | 2.160 |
Why?
|
| Lung | 15 | 2024 | 263 | 2.090 |
Why?
|
| Emphysema | 6 | 2021 | 12 | 1.940 |
Why?
|
| Tomography, X-Ray Computed | 15 | 2022 | 907 | 1.670 |
Why?
|
| Bone Density | 7 | 2022 | 169 | 1.270 |
Why?
|
| Forced Expiratory Volume | 11 | 2023 | 81 | 1.070 |
Why?
|
| Respiratory Function Tests | 12 | 2023 | 93 | 0.850 |
Why?
|
| Humans | 52 | 2024 | 32284 | 0.840 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 54 | 0.750 |
Why?
|
| Phenotype | 5 | 2023 | 622 | 0.710 |
Why?
|
| Male | 36 | 2024 | 19443 | 0.710 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2021 | 2 | 0.700 |
Why?
|
| Female | 36 | 2024 | 19947 | 0.700 |
Why?
|
| Hip Fractures | 1 | 2020 | 26 | 0.640 |
Why?
|
| Collagen Type I | 2 | 2018 | 44 | 0.620 |
Why?
|
| Cohort Studies | 13 | 2022 | 1840 | 0.620 |
Why?
|
| Heat-Shock Proteins | 2 | 2020 | 38 | 0.580 |
Why?
|
| HIV Infections | 3 | 2021 | 450 | 0.560 |
Why?
|
| Risk Factors | 15 | 2023 | 3934 | 0.560 |
Why?
|
| Middle Aged | 27 | 2023 | 11853 | 0.550 |
Why?
|
| Aged | 24 | 2023 | 10265 | 0.530 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 44 | 0.510 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 39 | 0.510 |
Why?
|
| Brain Ischemia | 1 | 2018 | 159 | 0.500 |
Why?
|
| Adiposity | 1 | 2017 | 190 | 0.480 |
Why?
|
| Pneumonectomy | 1 | 2016 | 12 | 0.470 |
Why?
|
| Absorptiometry, Photon | 4 | 2021 | 98 | 0.470 |
Why?
|
| Bronchoscopy | 1 | 2016 | 54 | 0.460 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 96 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 215 | 0.440 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 466 | 0.420 |
Why?
|
| Bone and Bones | 2 | 2014 | 91 | 0.410 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 427 | 0.400 |
Why?
|
| Airway Obstruction | 3 | 2021 | 29 | 0.400 |
Why?
|
| Disease Progression | 5 | 2023 | 591 | 0.390 |
Why?
|
| Spirometry | 3 | 2023 | 25 | 0.370 |
Why?
|
| Stroke | 1 | 2018 | 691 | 0.370 |
Why?
|
| Autoantibodies | 3 | 2020 | 50 | 0.350 |
Why?
|
| Interleukin-4 | 2 | 2013 | 22 | 0.340 |
Why?
|
| Adult | 13 | 2022 | 9259 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1158 | 0.320 |
Why?
|
| Quality of Life | 4 | 2023 | 964 | 0.310 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1479 | 0.310 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 2240 | 0.290 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 853 | 0.290 |
Why?
|
| Retrospective Studies | 5 | 2023 | 3628 | 0.270 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 520 | 0.250 |
Why?
|
| Muscles | 2 | 2023 | 69 | 0.240 |
Why?
|
| Pectoralis Muscles | 2 | 2021 | 4 | 0.220 |
Why?
|
| Comorbidity | 5 | 2021 | 565 | 0.210 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 11 | 0.210 |
Why?
|
| Atherosclerosis | 2 | 2023 | 820 | 0.210 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 40 | 0.200 |
Why?
|
| Leptin | 1 | 2023 | 61 | 0.200 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2013 | 7 | 0.200 |
Why?
|
| Mass Screening | 2 | 2020 | 256 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2021 | 1425 | 0.190 |
Why?
|
| Prognosis | 5 | 2021 | 1534 | 0.190 |
Why?
|
| Sarcopenia | 1 | 2022 | 50 | 0.180 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 116 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 158 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 167 | 0.170 |
Why?
|
| Serum Amyloid P-Component | 1 | 2021 | 3 | 0.170 |
Why?
|
| Metformin | 1 | 2021 | 25 | 0.170 |
Why?
|
| Body Mass Index | 3 | 2021 | 863 | 0.160 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 74 | 0.160 |
Why?
|
| F-Box Proteins | 1 | 2020 | 3 | 0.160 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 3 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2022 | 2316 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2021 | 120 | 0.160 |
Why?
|
| Muscle Development | 1 | 2020 | 52 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2021 | 174 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 227 | 0.150 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 8 | 0.150 |
Why?
|
| Skin Aging | 1 | 2019 | 9 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 87 | 0.150 |
Why?
|
| Pain | 1 | 2021 | 304 | 0.150 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 126 | 0.150 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 23 | 0.140 |
Why?
|
| Asthma | 1 | 2021 | 261 | 0.140 |
Why?
|
| Depression | 1 | 2021 | 420 | 0.140 |
Why?
|
| United States | 5 | 2022 | 4072 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 150 | 0.130 |
Why?
|
| Models, Biological | 1 | 2019 | 408 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 119 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1437 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 155 | 0.110 |
Why?
|
| Spinal Fractures | 1 | 2015 | 37 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2014 | 22 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 651 | 0.110 |
Why?
|
| Antibodies | 1 | 2014 | 56 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 101 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 58 | 0.110 |
Why?
|
| Software | 1 | 2014 | 124 | 0.100 |
Why?
|
| B-Cell Activating Factor | 1 | 2013 | 4 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2013 | 5 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 26 | 0.100 |
Why?
|
| Macrophages | 1 | 2014 | 207 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 79 | 0.100 |
Why?
|
| Sex Factors | 2 | 2015 | 657 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 129 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2012 | 273 | 0.090 |
Why?
|
| Incidence | 2 | 2015 | 1241 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 86 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2013 | 461 | 0.080 |
Why?
|
| Radiography | 1 | 2012 | 363 | 0.080 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 20 | 0.080 |
Why?
|
| Procollagen | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prevalence | 3 | 2019 | 955 | 0.080 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 25 | 0.080 |
Why?
|
| Young Adult | 2 | 2022 | 2649 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 287 | 0.080 |
Why?
|
| Algorithms | 3 | 2019 | 536 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 471 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2011 | 415 | 0.070 |
Why?
|
| Kidney | 1 | 2012 | 521 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2008 | 37 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 743 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 883 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1111 | 0.070 |
Why?
|
| Interleukin-13 | 1 | 2007 | 29 | 0.070 |
Why?
|
| Survival Rate | 2 | 2021 | 893 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1179 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 3902 | 0.060 |
Why?
|
| Cytokines | 1 | 2007 | 237 | 0.060 |
Why?
|
| Linear Models | 2 | 2020 | 425 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 395 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2024 | 12 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 17 | 0.050 |
Why?
|
| Acute Lung Injury | 1 | 2024 | 36 | 0.050 |
Why?
|
| Genomics | 1 | 2023 | 89 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2024 | 454 | 0.050 |
Why?
|
| Dyspnea | 1 | 2022 | 32 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 98 | 0.050 |
Why?
|
| Hand Strength | 1 | 2022 | 98 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 792 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 545 | 0.040 |
Why?
|
| Airway Remodeling | 1 | 2021 | 5 | 0.040 |
Why?
|
| Research Design | 2 | 2014 | 314 | 0.040 |
Why?
|
| Plethysmography | 1 | 2021 | 18 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 324 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 51 | 0.040 |
Why?
|
| Organ Size | 1 | 2021 | 221 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 24 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 773 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1083 | 0.040 |
Why?
|
| Myoblasts, Skeletal | 1 | 2020 | 21 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 327 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 346 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 757 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 203 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 290 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 41 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 10 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 138 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 192 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 186 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 193 | 0.040 |
Why?
|
| Mice | 1 | 2024 | 2571 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 506 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 839 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2019 | 211 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2016 | 72 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 456 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 80 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 120 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 3519 | 0.030 |
Why?
|
| Computational Biology | 1 | 2014 | 99 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2014 | 251 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3416 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 22 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 184 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 8199 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 191 | 0.020 |
Why?
|
| Education | 1 | 2012 | 31 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 302 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 854 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|